Immuneering IMRX
NASDAQ IMRX
$4.03 -0.06 (-1.59%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immuneering (IMRX) Long-Term Investments (2021 - 2026)

Updated

Immuneering's Long-Term Investments was $32.77 million in Q2 2026, down 21.9% from the prior quarter.

Analysis

Immuneering (IMRX) Long-Term Investments (2021 - 2026) Analysis & Trends

At the end of FY2025, Long-Term Investments at Immuneering came in at $44.18 million.

  • Long-Term Investments shows a four-year compound annual growth rate of 158.0% (FY2021 to FY2025).
  • In earlier years, Long-Term Investments was $996,560 in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Long-Term Investments since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Immuneering 264.61 Mn 264.61 Mn - 32.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.77 Mn
Mar 31, 2026 41.95 Mn
Dec 31, 2025 44.18 Mn
Dec 31, 2021 996,560.00
Sep 30, 2021 10.10 Mn
API Access

Immuneering Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IMRX&period=max&api_key=YOUR_API_KEY